ORNAVOrion Oyj
71.70EUR+2.14%Mkt Cap: 10.98B $P/E: 19.07

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. It offers pharm…

Indicators:|

Key Statistics

Company
Market Cap10.98B $
Enterprise Value11.12B $
Revenue (TTM)2.12B $
Gross Profit1.32B $
Net Income (TTM)543.80M $
Revenue/Share15.08 USD
Last Price71.70 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4.1K
CountryFI
SectorHealthcare
IndustryDrug Manufacturers - General
ISINFI0009014377
Valuation
P/E (Trailing)19.07
P/E (Forward)
PEG5.73
EV/EBITDA14.19
EV/Revenue5.24
P/S5.17
P/B9.00
EPS (TTM)3.76
EPS (Forward)
52W Range
56.3082% of range75.10
52W High75.10 EUR
52W Low56.30 EUR
Profitability
Gross Margin64.20%
Oper. Margin27.46%
EBITDA Margin36.91%
Profit Margin26.48%
ROE38.95%
ROA24.89%
Growth
Revenue Growth17.80%
Earnings Growth46.70%
Cash Flow & Leverage
Operating CF344.35M $
CapEx (TTM)106.09M $
FCF Margin16.81%
FCF Yield3.25%
Net Debt142.39M $
Net Debt/EBITDA0.18
Balance Sheet
Debt/Equity0.24
Current Ratio1.77
Quick Ratio1.13
Book Value/Sh7.968 EUR
Cash/Share1.415 EUR
Dividends
Fwd Div Rate1.800 EUR
Trail. Div Rate1.800 EUR
Div. Yield2.54%
5Y Avg Yield3.29%
Payout Ratio45.74%
Ex-Div DateOct 19, 2026
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.31.52M
Float123.11M
Insiders32.61%
Institutions7.99%
Technical
SMA 5069.51 (+3.2%)
SMA 20066.89 (+7.2%)
Beta0.28
S&P 52W Chg20.05%
Avg Vol (30d)5.07K
Avg Vol (10d)5.17K
Technical Indicators
RSI (14)60.3
MACD0.1469
MACD Signal-0.2094
MACD Hist.+0.3563
BB Upper71.65 EUR
BB Middle68.96 EUR
BB Lower66.28 EUR
BB Width7.78%
ATR (14)1.642 EUR
Vol Ratio (20d)0.50x